Immunohistochemical analysis of CD155 expression in triple-negative breast cancer patients.
<h4>Introduction</h4>CD155 is an immune checkpoint protein. Its overexpression is an indicator of poor prognosis in some types of cancer. However, the significance of CD155 expression in patients with triple-negative breast cancer, and the relationship between CD155 and programmed death-...
| Huvudupphovsmän: | , , , , , |
|---|---|
| Materialtyp: | Artikel |
| Språk: | English |
| Publicerad: |
Public Library of Science (PLoS)
2021-01-01
|
| Serie: | PLoS ONE |
| Länkar: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0253176&type=printable |